Stay updated on Switchover Trial Imiglucerase to Plant Cell Express Clinical Trial

Sign up to get notified when there's something new on the Switchover Trial Imiglucerase to Plant Cell Express Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Switchover Trial Imiglucerase to Plant Cell Express Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The clinical trial record for a Gaucher disease switchover study is displayed instead of an error page. It provides information about taliglucerase alfa treatment, participant eligibility, study measures, and participating locations.
    Difference
    45%
    Check dated 2026-11-07T12:19:07.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The footer now displays revision v3.8.0 instead of v3.7.2; the page continues to show a 403 Forbidden error rather than the study record.
    Difference
    0.2%
    Check dated 2026-10-31T12:42:04.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    An NIH banner announces a transition in terminology, saying federal agencies are using “Super Intelligence” instead of “Artificial Intelligence” and linking to related updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T13:28:00.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2 on the ClinicalTrials.gov error page.
    Difference
    0.2%
    Check dated 2026-10-17T13:35:08.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The site footer’s revision identifier changed from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T14:27:37.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study record content with an access-denied view. This indicates that the study information is not accessible through the current path.
    Difference
    17%
    Check dated 2026-09-19T17:44:41.000Z thumbnail image

Stay in the know with updates to Switchover Trial Imiglucerase to Plant Cell Express Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Switchover Trial Imiglucerase to Plant Cell Express Clinical Trial page.